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Abstract In this study, quantitative and pattern recogni-
tion analyses were developed using HPLC/UV for the
quality evaluation of Dipsaci Radix. For quantitative
analysis, five major bioactive compounds were assessed.
The separation conditions employed for HPLC/UV were
optimized using ODS C18 column (250 9 4.6 mm, 5 lm)
with a gradient of acetonitrile and water as the mobile
phase at a flow rate of 1.0 mL/min and a detection wave-
length of 212 nm. These methods were fully validated with
respect to linearity, accuracy, precision, recovery, and
robustness. The HPLC/UV method was applied success-
fully to the quantification of five major compounds in the
extract of Dipsaci Radix. The HPLC analytical method for
pattern recognition analysis was validated by repeated
analysis of 17 Dipsaci Radix and four Phlomidis Radix
samples. The results indicate that the established HPLC/
UV method is suitable for quantitative analysis.
Keywords Dipsaci Radix  Dipsacus asperoides 
HPLC–UV  Quality control
Introduction
The use of herbal medicines continues to expand rapidly
throughout the world. Many people now take herbal med-
icines or herbal products for their health in different
national health-care settings (WHO 2004). The require-
ments and methods for quality control of finished herbal
products, particularly for mixed herbal products, are far
more complex than for other pharmaceuticals. The quality
of such products is influenced by the quality of the raw
materials used. Good agricultural and good collection
practices (GACP) for medicinal plants, including plant
selection and cultivation, are therefore important measures
(WHO 2003). Quality control in synthetic drugs is con-
ducted by measuring their medicinal components, whereas
quality control in herbal medicines is traditionally per-
formed by measuring a representative compound (a marker
compound) contained in the herbal medicines. However,
quantitation of one or a few components is not an adequate
approach for quality control of herbal medicines. Thus
there is an urgent need to establish a comprehensive
qualified evaluation method based on analysis of the bio-
active compounds in order to accurately reflect the quality
of herbal medicines. Fingerprint analysis/pattern recogni-
tion with multivariate statistical analysis can provide
information regarding the overall chemical composition of
herbal medicines, including the marker compounds tradi-
tionally used for quality control (Islam et al. 2009).
Dipsaci Radix is the roots of Dipsacus asperoides
C. Y. Cheng et T. M. Ai (Dipsacaceae) in the Korean
Herbal Pharmacopoeia (K. H. P.) (Korea Food and Drug
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Administration 2007) and the Chinese Pharmacopoeia (C.
P.). Dipsaci Radix is controlled to contain[2 % of akebia
saponin D in C. P. (Pharmacopoeia Commission of Peo-
ple’s Republic of China 2010). Various saponins (Hung
et al. 2005; Oh et al. 1999), iridoids (Tomita and Mouri
1996) and phenylpropanoids (Inoue et al. 1989) have been
isolated from Dipsaci Radix. Biological studies have
revealed that this plant possesses antioxidant (Hung et al.
2006), anti-inflammatory (Jung et al. 2012), anticomple-
mentary (Oh et al. 1999), and cytotoxic effects (Tomita and
Mouri 1996; Zhou et al. 2009).
Dipsaci Radix and Phlomidis Radix are different spe-
cies. Phlomidis Radix is the roots of Phlomis umbrosa
Turczaninow in the Korean Herbal Pharmacopoeia (K.
H. P.) (Korea Food and Drug Administration 2007).
However, Phlomidis Radix has often been misused as
Dipsaci Radix in the Korean market because of similarities
in their names and shapes. Therefore, we have selected
Phlomidis Radix as a comparative herbal medicine. There
is no report on the differentiation between Dipsaci Radix
and Phlomidis Radix.
Some HPLC/UV analytical methods have been devel-
oped for the analysis of Dipsaci Radix and its related
products. Ma et al. (2007) and Wang et al. (2006) reported
akebia saponin D as a specific marker for the distinction of
Dipsaci Radix. Those studies focused only on quantitative
analysis of akebia saponin D, which is not a promising
approach for the quality control or fingerprinting analysis
of herbal drugs. However, as multiple compounds might be
associated with therapeutic functions, a single marker
compound could not be responsible for the overall phar-
macological activities of Dipsaci Radix. Therefore, there is
an urgent need to establish a comprehensive quality eval-
uation method based on analysis of a variety of active
compounds in order to accurately reflect the quality of
these herbal drugs. In the present study, a simple, sensitive
and precise reverse-phase HPLC/UV method has been
developed for the quantitative determination of five marker
components, loganin (1), sweroside (2), dipsanoside A (3),
3-O-[b-D-glu-(1?4)][a-L-rha-(1?3)]-b-D-glu(1?3)-a-L-
rha-(1?2)-a-L-ara-hed 28-O-b-D-glu-(1?6)-b-D-glu ester
(4) and akebia saponin D (5), along with a pattern-recog-
nition method for the quality control of Dipsaci Radix
extract. Using this method, the contents of bioactive com-
pounds in seventeen Dipsaci Radix and four Phlomidis
Radix samples from China and Korea were analyzed and
compared.
Using this method, the contents of bioactive compounds
in seventeen Dipsaci Radix from China and four Phlomidis
Radix from Korea samples were analyzed and compared.
We used all Dipsaci Radix samples from China, because
its Korean samples couldn’t be available in the herbal
markets. The PAM method of pattern analysis was subsequently




Twenty-one samples including seventeen Dipsaci Radix
and four Phlomidis Radix samples cultivated in different
regions were provided by the National Center for Stan-
dardization of Herbal Medicine. Dipsaci Radix (D01–D17)
and Phlomidis Radix (P18–P21) included D01 (Si Chuan
Sheng, China), D02 (Ji Zhou, China), D03 (unknown area,
China), D04 (unknown area, China), D05 (unknown area,
China), D06 (unknown area), D07 (unknown area), D08
(unknown area), D09 (unknown area, China), D10
(unknown area), D11 (An Guo, China), D12 (Si Chuan
Sheng, China, processed with salt-water), D13 (unknown
area, processed with salt-water), D14 (unknown area,
processed with wine), D15 (Si Chuan Sheng, China, pro-
cessed with wine), D16 (Nan Zhou, China), D17 (unknown
area, China), P18 (Yeong Cheon, Korea), P19 (Je Chon,
Korea), P20 (Yeong Cheon, Korea) and P21 (Yeong
Cheon, Korea).
Reagents
All of the standard compounds were provided by Prof. Kun
Ho Son, Andong National University, Andong, Korea.
Their structures were unambiguously identified as loganin
(1), sweroside (2), dipsanoside A (3), 3-O-[b-D-glu-
(1?4)][a-L-rha-(1?3)]-b-D-glu(1?3)-a-L-rha-(1?2)-a-L-
ara-hed 28-O-b-D-glu-(1?6)-b-D-glu ester (4) and akebia
saponin D (5) based on NMR and MS data compared with
published data. The standard compound structures are
shown in Fig. 1. Purity of standard compounds was esti-
mated to be higher than 95 % based on HPLC and LC–MS/
MS analysis. Internal standard (I.S.), pulsatilla saponin H,
was provided as powder from Prof. Sam Sik Kang, Seoul
National University. HPLC-grade methanol and acetoni-
trile were purchased from Merck K GaA (Darmstadt,
Germany). All other chemicals used were of analytical
grade unless otherwise noted. Distilled water was prepared
using Milli-Q purification system (Millipore, Bedford, MA,
USA).
Sample preparation
Dried rhizome powder was used to determine the contents
of the five marker compounds and pattern recognition
analysis of each extraction of Dipsaci Radix. Powdered
Dipsaci Radix was sieved through 50 mesh, and about
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0.5 g of the powder was accurately weighed; 25 mL of
50 % methanol were added, the weight was accurately
measured, and the sample was sonicated for 30 min. The
solution was weighed again, and the loss in weight was
made up with 50 % methanol. The solution was filtered
through a 0.45-lm membrane filter and the filtrate was
used as the test solution. Sample solution of 20 lL was
injected into the HPLC system.
HPLC/UV conditions
The HPLC equipment was a Waters HPLC system (Waters,
Milford, MA, USA) with a Waters 600 pumps, a Waters
486 UV detector and a Waters 717 autosampler. YMC
ODS-H80 (250 9 4.6 mm, 4 lm), Shiseido capcell pak
(250 9 4.6 mm, 5 lm) and Shodex ODS pak (250 9 4.6 mm,













































































































1. loganin                           2. sweroside 
3. dipsanoside A                     I.S. pulsatilla saponin H 
5. akebia saponin D
Fig. 1 Chemical structures of standards
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the same stationary phase. A (100 % acetonitrile) and B
(water) were used as the mobile phase under a gradient con-
dition (0 min, 15 % A; 60 min, 35 % A). The mobile phase
was filtered under vacuum through a 0.45-lm membrane filter
and degassed prior to use. The analysis was carried out at a
flow rate of 1.0 mL/min with the detection wavelength set to
212 nm, and the total run time was 60 min. All compounds
could be resolved with baseline separation at 212 nm with
maximum absorption. Hence, characteristic chromatographic
patterns were obtained at 212 nm. The chromatograms were
processed using Empower Pro software, Build 1154 (Waters,
Milford, MA).
Analytical method validation
The standards (4 mg) of loganin (1), sweroside (2),
dipsanoside A (3), 3-O-[b-D-glu-(1?4)][a-L-rha-(1?3)]-
b-D-glu(1?3)-a-L-rha-(1?2)-a-L-ara-hed 28-O-b-D-glu-
(1?6)-b-D-glu ester (4) and akebia saponin D (5) were
each accurately weighed and then dissolved in 10 mL of
100 % methanol to produce stock standard solutions of
400 ppm. The internal standard (pulsatilla saponin H;
15 mg) was accurately weighed and then dissolved in
10 mL of 100 % methanol to produce a stock solution of
1,500 ppm. The calibration curves were made by diluting
the stock solutions with 100 % methanol. A reference
solution of the five standard compounds at concentrations
of 0.1–200 lg/mL was analyzed by HPLC/UV. The
regression equations were calculated in the form of
y = ax ? b, where y and x correspond to peak area ratio
for internal standard and compound concentration,
respectively. Recovery tests were executed by mixing a
powdered sample (0.5 g) with the reference compounds at
three control levels (near the LOQ, medium and higher
concentrations for calibration curve of each compound
contained in the samples). The mixture was then extracted
by sonication in 25 mL of 50 % methanol for 30 min. The
extract solution was filtered through a 0.45-lm membrane.
The HPLC/UV analysis experiments were performed in
triplicate for each control level. The data from the standard
solution and the extracted sample were compared. Preci-
sion and accuracy were determined by multiple analyses
(n = 5) of quality control samples prepared at low, med-
ium and high concentrations spanning the calibration
range.
Pattern recognition analysis
To evaluate the phytochemical equivalency among the 21
samples comprising seventeen Dipsaci Radix and four
Phlomidis Radix samples, pattern recognition analysis was
conducted. In this study we used three marker compound
peaks [sweroside (2), dipsanoside A (3) and akebia saponin
D (5)] for pattern recognition analysis. Pattern recognition
analysis was conducted using software package R-2.11.0.
Results and discussion
Optimization of chromatographic conditions
The HPLC conditions were selected according to the
requirement for obtaining chromatograms with better res-
olution of adjacent peaks within a short retention time. For
the optimization of chromatographic conditions, the effect
of the mobile phase composition on the separation was
examined. A mobile phase of water–methanol did not
result in satisfactory separation of structurally similar
compounds. Acetonitrile as an organic modifier signifi-
cantly improved the separation. We also tested the addition
of 0.1, 1 and 10 % acid (acetic acid, formic acid and
phosphoric acid) in the water. The water without acid
resulted in good resolution of all compounds, as well as
satisfactory peak symmetry and shape. The typical chro-
matograms of samples and standard mixture are shown in
Fig. 2, which shows that all target compounds and an
internal standard are completely separated within 60 min.
Pulsatilla saponin H (I.S.) was selected as an internal
standard. The chromatographic peaks of the analytes in
sample solution were identified by comparing their reten-
tion times with those of the reference standards and were
further confirmed by spiking samples with reference
compounds (Fig. 2). All compounds could be resolved with
baseline separation at 212 nm with the maximum absorp-
tion shown for the five constituents. Hence, characteristic
chromatographic patterns were obtained at 212 nm.
Optimization of sample preparation conditions
Eight extracting solvents, 100 % ethanol, 75 % ethanol,
50 % ethanol, 25 % ethanol, 100 % methanol, 75 %
methanol, 50 % methanol and 25 % methanol, were com-
pared in sample assays after sonication for 30 min. When
the sample was extracted with 50 % methanol, the sample
assay was higher than the other solvent samples. Therefore,
we employed 50 % methanol as the extracting solvent
throughout this work. Two extraction methods, ultra-soni-
cation and reflux using 50 % methanol as an extraction
solvent, were compared in sample assays. The sample
assay results after the sonication extraction method were
higher than those after reflux. To determine the time nee-
ded for complete extraction, samples were extracted for
five different lengths of time (10, 20, 30, 40 and 60 min).
Thus 50 % methanol solvent and the sonication extraction
method were employed. When the extraction time was
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30 min, the sample assay results were similar to those at
40 min. Therefore, when the extraction time was 30 min,
all of the compounds were sufficiently extracted.
Validation of the method
Linearity, calibration range, limits of detection
and quantification
Each coefficient of correlation (r2) was [ 0.999, as
determined by least square analysis, suggesting good
linearity between the peak area ratio and the compound
concentrations (Table 1). The limits of detection (LOD)
and limits of quantitation (LOQ) were evaluated based on
the lowest detectable peak in the chromatogram having a
signal-to-noise (S/N) ratio of 3 and 10, respectively. The
LOD and LOQ under our experimental conditions are
listed in Table 1. The obtained values for both LOD and
LOQ for these five standards were low enough to detect
traces of these compounds in either crude extract or its
preparation.
Precision and accuracy
The extraction recovery test was performed by extracting a
known amount of the five compounds from the Dipsaci
Radix powder samples. Known amounts of each standard
compound at three levels were mixed with the sample
powder and extracted with 50 % methanol, as described in
the experimental section. The % recovery of each standard
ranged from 97.98 to 105.12 %, and the RSD was\1.44 %
(Table 2). The average recovery was represented by the
formula: R (%) = [(amount from the sample spiked stan-
dard - amount from the sample)/amount from the spiked
standard] 9 100.
Intra-assay precision and accuracy were determined
from the variability of multiple analyses (n = 5) of quality
control samples analyzed within the same analytical run.
The quality control samples had intra-assay precision
below 0.50 % and accuracy between 96.67 and 102.49 %.
Inter-assay precision and accuracy were evaluated from the
variability of multiple analyses (n = 5) of quality control
samples analyzed on a single analytical run for consecutive
5 days. The quality control samples had an inter-assay
Fig. 2 HPLC chromatograms
of standard mixture (a), Dipsaci
Radix (b) and Phlomidis Radix
(c). 1 loganin, 2 sweroside, 3




D-glu ester, 5 akebia saponin D,
I.S. pulsatilla saponin H
Table 1 Linearity, linear
ranges, LOD and LOQ
1 loganin, 2 sweroside, 3

















1 0.1–40 0.079 0.0318 0.9998 120 350
2 0.1–40 0.054 -0.0120 0.9999 140 320
3 0.1–50 0.1745 -0.0057 0.9999 100 290
4 0.1–100 0.0389 -0.0508 0.9998 130 270
5 0.1–200 0.0376 -0.0522 0.9999 120 330
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Table 2 Recoveries of marker
compounds through standard
addition (n = 6)
1 loganin, 2 sweroside, 3




D-glu ester, 5 akebia saponin D











1 0.0 8.47 – – 105.12
0.4 8.92 0.30 112.50
20.0 28.89 0.38 102.10
40.0 48.77 0.06 100.75
2 0.0 51.29 – – 99.35
0.4 51.26 0.20 92.50
20.0 72.15 0.11 104.30
40.0 91.79 0.04 101.25
3 0.0 17.38 – – 101.49
0.3 17.69 0.50 103.33
20.0 37.67 0.04 101.45
50.0 67.22 0.02 99.68
4 0.0 80.13 – – 97.98
0.3 80.42 0.04 96.67
50.0 128.20 0.02 96.14
100.0 181.26 0.01 101.13
5 0.0 111.27 – – 101.72
0.3 111.58 0.07 103.33
100.0 211.5 0.01 100.23
200.0 314.48 0.01 101.61
Table 3 Precision and accuracy of analytical results (n = 5)
Analytes Nominal
conc.a (lg/mL)










1 0.4 0.41 0.01 102.49 0.30 0.41 0.02 102.50 1.06
20.0 20.09 0.01 100.45 0.38 20.03 0.08 100.15 1.62
40.0 40.04 0.01 100.10 0.06 40.05 0.14 100.13 1.40
2 0.4 0.39 0.02 97.50 0.20 0.39 0.06 97.50 0.58
20.0 19.78 0.02 98.91 0.11 20.12 0.47 100.60 2.42
40.0 40.01 0.02 100.02 0.04 40.19 0.91 100.48 2.34
3 0.3 0.31 0.02 96.67 0.50 0.31 0.10 103.33 2.08
20.0 20.07 0.03 100.34 0.04 20.02 0.13 100.10 1.26
50.0 49.78 0.01 99.57 0.02 50.06 0.36 100.12 1.79
4 0.3 0.29 0.01 96.67 0.04 0.30 0.42 100.00 2.11
50.0 49.72 0.02 99.44 0.02 49.98 0.49 99.96 1.21
100.0 99.92 0.02 99.92 0.01 100.36 0.93 100.36 1.71
5 0.3 0.29 0.02 96.67 0.07 0.30 0.35 100.00 1.40
100.0 99.88 0.01 99.88 0.01 100.04 0.55 100.04 1.10
200.0 200.09 0.01 100.05 0.01 200.12 0.61 100.06 0.62
a Added concentration of standard
b Amount from the sample spiked standard - amount from the sample
c Standard deviation
d (Observed/added) 9 100
e The relative standard deviation of accuracy
1 loganin, 2 sweroside, 3 dipsanoside A, 4 3-O-[b-D-glu-(1?4)][a-L-rha-(1?3)]-b-D-glu(1?3)-a-L-rha-(1?2)-a-L-ara-hed 28-O-b-D-glu-
(1?6)-b-D-glu ester, 5 akebia saponin D
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precision of \2.42 % and accuracy between 97.50 and
103.33 %. Thus, the developed method is highly repro-
ducible; the precision and accuracy data are presented in
Table 3.
Robustness
The robustness was determined in order to evaluate the
reliability of the established HPLC method. All of the
parameters were maintained so there would not be any
interference with other peaks for the Dipsaci Radix. The
experimental conditions, such as column temperature,
column species and flow rate, were purposely altered. The
theoretical plate (N), capacity factor (k0), separation factor
(a) and resolution (Rs) were evaluated. To evaluate their
suitability, three different columns, YMC, Phenomenex
and Shodex, were compared with regard to four analytical
factors (N, k0, a and Rs) on the column temperature of
30 C. The result showed that the four analytical factors
did not differ greatly among the column species. Four
different column temperatures, 25, 30, 35 and 40 C, were
compared with regard to these four analytical factors using
the YMC column. Again the four analytical factors did not
differ greatly by column temperature. Three different flow
rates, 0.9, 1.0 and 1.1 mL/min, were also compared with
regard to the four analytical factors using the YMC column
at 30 C. The four analytical factors did not differ greatly
by flow rate. We sought to optimize the chromatographic
parameters, but the four analytical factors did not differ
greatly when the conditions were changed; therefore these
experimental conditions were sufficiently robust.
The sample stability was tested with a standard mixture
solution at 0, 0.5, 1, 2, 5, 10, 15 and 30 days. During this
period, the solution was stored in the dark at room tem-
perature or at 4 C. The resulting data indicated that all
marker analytes remained stable (99.99 %) during the
experimental period.
Sample analysis
The developed HPLC/UV method was then applied to the
simultaneous determination of the five compounds, loganin
(1), sweroside (2), dipsanoside A (3), 3-O-[b-D-glu-
(1?4)][a-L-rha-(1?3)]-b-D-glu(1?3)-a-L-rha-(1?2)-a-L-
ara-hed 28-O-b-D-glu-(1?6)-b-D-glu ester (4) and akebia
saponin D (5) in Dipsaci Radix and Phlomidis Radix. The
quantity of each compound present in samples was deter-
mined and the results are summarized in Table 4. Each
sample was analyzed in triplicate to ensure the reproduc-
ibility of the quantitative result. Loganin (0.01–0.38 %),
Table 4 Contents (wt%) of five
components in Dipsaci Radix
(D01–D17) and Phlomidis
Radix (P18–P21) samples
a Each value represents the
mean ± S.D. (n = 3)
b The average contents of all
the Dipsaci Radix (D01–D17)
Sample Contents (w/w %)
1 2 3 4 5
D01 0.06 ± 0.01a 0.98 ± 0.01 0.29 ± 0.01 1.67 ± 0.06 10.62 ± 0.52
D02 0.01 ± 0.00 0.28 ± 0.00 0.15 ± 0.01 1.60 ± 0.06 3.61 ± 0.09
D03 0.22 ± 0.01 0.87 ± 0.02 0.28 ± 0.01 0.88 ± 0.01 10.81 ± 0.29
D04 0.08 ± 0.01 0.75 ± 0.00 0.24 ± 0.01 1.70 ± 0.03 10.96 ± 0.10
D05 0.01 ± 0.00 0.52 ± 0.02 0.39 ± 0.01 1.05 ± 0.02 6.41 ± 0.16
D06 0.05 ± 0.01 0.73 ± 0.03 0.24 ± 0.02 1.53 ± 0.02 8.14 ± 0.13
D07 0.07 ± 0.01 0.42 ± 0.01 0.27 ± 0.01 0.83 ± 0.03 4.80 ± 0.05
D08 0.04 ± 0.01 0.40 ± 0.02 0.20 ± 0.01 0.84 ± 0.01 5.05 ± 0.06
D09 0.05 ± 0.01 0.73 ± 0.01 0.35 ± 0.01 1.26 ± 0.03 9.18 ± 0.30
D10 0.07 ± 0.01 0.70 ± 0.01 0.36 ± 0.01 1.21 ± 0.02 4.00 ± 0.16
D11 0.11 ± 0.01 0.28 ± 0.01 0.14 ± 0.00 0.44 ± 0.01 3.71 ± 0.10
D12 0.06 ± 0.01 0.64 ± 0.02 0.28 ± 0.00 1.28 ± 0.04 1.70 ± 0.01
D13 0.16 ± 0.01 0.38 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.73 ± 0.02
D14 0.38 ± 0.01 0.70 ± 0.02 0.08 ± 0.01 0.44 ± 0.02 3.16 ± 0.06
D15 0.15 ± 0.01 0.87 ± 0.03 0.13 ± 0.01 0.55 ± 0.01 9.16 ± 0.14
D16 0.05 ± 0.01 0.55 ± 0.02 0.22 ± 0.01 1.36 ± 0.06 7.30 ± 0.24
D17 0.01 ± 0.00 0.32 ± 0.00 0.18 ± 0.01 0.98 ± 0.03 5.45 ± 0.15
Averageb 0.09 ± 0.00 0.60 ± 0.01 0.22 ± 0.01 1.04 ± 0.04 6.16 ± 0.12
P18 – – – – –
P19 – – – – –
P20 – – – – –
P21 – – – – –
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sweroside (0.28–0.98 %), dipsanoside A (0.01–0.39 %),
3-O-[b-D-glu-(1?4)][a-L-rha-(1?3)]-b-D-glu(1?3)-a-
L-rha-(1?2)-a-L-ara-hed 28-O-b-D-glu-(1?6)-b-D-glu ester
(0.01–1.70 %) and akebia saponin D (0.73–10.96 %) were
found in Dipsaci Radix. These Dipsaci Radix components
clustered into one group, and the most abundant component
was akebia saponin D (0.73–10.96 %). Contents of akebia
saponin D in D12 and D13 for salt-water processing were
1.70 and 0.73 %, respectively. Neither D12 nor D13 was
suitable based on the regulation of [2 % in the Chinese
Pharmacopoeia [5]. Thus, the major compounds in Dipsaci
Radix appeared to change due to salt-water processing. In
contrast, compounds 1–5 were not completely contained in
Phlomidis Radix as a comparison herbal medicine. In the
quantitative analysis, Dipsaci Radix and Phlomidis Radix
samples clustered into two groups as mentioned below.
Pattern recognition analysis
To evaluate the phytochemical equivalency between 17
Dipsaci Radix and four Phlomidis Radix samples, pattern
recognition analysis was conducted. In this study we used
three marker compound peaks [sweroside (2), dipsanoside
A (3) and akebia saponin D (5)] for pattern recognition
analysis. Even though the content of compound 4 in
Dipsaci Radix was higher than those of compounds 2 and
3, we selected 2, 3 and 5 as marker compounds rather than
4 because of difficulties in the isolation and the availability
of 4. From the pattern analysis of Partitioning Around
Medoids (PAM) analyses (Fig. 3), all of the samples were
clustered into two groups: A (D01–D17, Dipsaci Radix)
and B (P18–P21, Phlomidis Radix).
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